FIELD: medicine.
SUBSTANCE: use of a peptide, which is sodium gamma-D-glutamyl-D-tryptophan as an antiallergic drug for treatment or prevention of pathological conditions with allergic syndrome, selected from at least one: allergic rhinitis, allergic conjunctivitis, allergic bronchial asthma, is proposed.
EFFECT: relief of residual manifestations in the disease remission.
3 cl, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION BASED ON CLOZAPINE OF PERORAL INTRODUCTION | 2009 |
|
RU2414903C1 |
DRUG FOR GASTROINTESTINAL TRACT AND HEPATOBILIARY SYSTEM DISEASES TREATMENT AND PREVENTING RECRUDESCENCES | 2017 |
|
RU2651711C1 |
AGENT FOR TREATING FUNCTIONAL GASTROINTESTINAL DISEASES | 2020 |
|
RU2740750C1 |
METHOD OF TREATING CHRONIC RECURRENT ALLERGIC DISEASES OF NASAL MUCOSA AND PARANASAL SINUSES BY ENDONASAL AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2411048C1 |
METHOD OF TREATING ALLERGIC DISEASES BY AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2395305C1 |
0 |
|
SU1776414A1 | |
METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA WITH USING NEUROLEPTIC COMBINED THERAPY | 2007 |
|
RU2508096C2 |
METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA WITH USING ATYPICAL NEUROLEPTIC COMBINED THERAPY | 2007 |
|
RU2508106C2 |
APPLICATION OF SEMAX PREPARATION FOR TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2347582C1 |
METHOD FOR TREATMENT OF PATIENTS WITH ALLERGIC DISEASES BY AUTOLOGICAL LYMPHOCYTES | 2015 |
|
RU2633343C2 |
Authors
Dates
2017-11-17—Published
2016-11-17—Filed